Permanent URL to this publication: http://dx.doi.org/10.5167/uzh-50505
Hofer, S; Elandt, K; Greil, R; Hottinger, A F; Huber, U; Lemke, D; Marosi, C; Ochsenbein, A; Pichler, J; Roelcke, U; Weder, P; Zander, T; Wick, W; Weller, M (2011). Clinical outcome with bevacizumab in patients with recurrent high-grade glioma treated outside clinical trials. Acta Oncologica, 50(5):630-635.
PDF - Registered users only
View at publisher
Our data reveal valuable palliation with preservation of KPS and an option for steroid withdrawal in patients treated with BEV, supporting the role of this therapy in late-stage disease.
0 downloads since deposited on 14 Nov 2011
0 downloads since 12 months
|Item Type:||Journal Article, refereed, original work|
|Communities & Collections:||04 Faculty of Medicine > University Hospital Zurich > Clinic for Neurology|
|DDC:||610 Medicine & health|
|Deposited On:||14 Nov 2011 13:37|
|Last Modified:||22 Jan 2014 06:23|
|Publisher:||Taylor & Francis|
Users (please log in): suggest update or correction for this item
Repository Staff Only: item control page